PHARMACOKINETICS OF HALOPERIDOL

被引：118
|
作者：
FROEMMING, JS
LAM, YWF
JANN, MW
DAVIS, CM
机构：
[1] MERCER UNIV,SO SCH PHARM,DEPT PHARM PRACTICE,ATLANTA,GA
[2] UNIV TEXAS,HLTH SCI CTR,DIV CLIN PHARM,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] UNIV TEXAS,INST MENTAL SCI INST,HOUSTON,TX 77025
来源：
CLINICAL PHARMACOKINETICS | 1989年 / 17卷 / 06期
关键词：
D O I：
10.2165/00003088-198917060-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：396 / 423
页数：28
相关论文
共 50 条
  • [41] PHARMACOKINETICS AND THERAPEUTIC EFFICACY OF HALOPERIDOL DECANOATE AFTER LOADING DOSE ADMINISTRATION
    DECUYPER, H
    BOLLEN, J
    VANPRAAG, HM
    VERSTRAETEN, D
    BRITISH JOURNAL OF PSYCHIATRY, 1986, 148 : 560 - 566
  • [42] EFFECT OF AGE ON PHARMACOKINETICS OF HALOPERIDOL, PHENOBARBITAL, AND METHADONE IN EXPERIMENTAL-ANIMALS
    KAPETANOVIC, IM
    GERODONTOLOGY, 1986, 5 (01) : B57 - B57
  • [43] THE BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL AND DEPOT INTRAMUSCULAR HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
    NAYAK, RK
    DOOSE, DR
    NAIR, NPV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (02): : 144 - 150
  • [44] Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats
    Watanabe, M
    Tateishi, T
    Asoh, M
    Nakura, H
    Tanaka, M
    Kumai, T
    Kobayashi, S
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (03) : 337 - 342
  • [45] Pharmacokinetics and bioequivalence of haloperidol tablet by liquid chromatographic mass spectrometry with electrospray ionization
    Yun, MH
    Kwon, JT
    Kwon, KI
    ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (04) : 488 - 492
  • [46] Pharmacokinetics and bioequivalence of haloperidol tablet by liquid chromatographic mass spectrometry with electrospray ionization
    Min-Hyuk Yun
    Jun-Tack Kwon
    Kwang-il Kwon
    Archives of Pharmacal Research, 2005, 28 : 488 - 492
  • [47] Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients
    Yukawa, E
    Hokazono, T
    Yukawa, M
    Ichimaru, R
    Maki, T
    Matsunaga, K
    Ohdo, S
    Anai, M
    Higuchi, S
    Goto, Y
    CLINICAL PHARMACOKINETICS, 2002, 41 (02) : 153 - 159
  • [48] Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice
    Kirschbaum, Katrin M.
    Henken, Stefanie
    Hiemke, Christoph
    Schmitt, Ulrich
    BEHAVIOURAL BRAIN RESEARCH, 2008, 188 (02) : 298 - 303
  • [49] INFLUENCE OF NUTRITIONAL-STATUS IN INTRAVENOUS PHARMACOKINETICS OF HALOPERIDOL IN PSYCHOTIC-PATIENTS
    DONOSO, A
    VERA, G
    ARANCIBIA, A
    DIAZ, E
    SCHILKRUT, R
    MISERDA, R
    KOHEN, P
    PAK, N
    REVISTA MEDICA DE CHILE, 1984, 112 (08) : 777 - 783
  • [50] Pharmacodynamics and pharmacokinetics related gene polymorphisms affect adverse drug reactions of haloperidol
    Zastrozhin, M.
    Sychev, D.
    Baymeeva, N.
    Miroshnichenko, I.
    Grishina, E.
    Bryun, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 : S4 - S5
12345